` ENL (Enlitic Inc) vs S&P/ASX 300 Comparison - Alpha Spread

ENL
vs
S
S&P/ASX 300

Over the past 12 months, ENL has underperformed S&P/ASX 300, delivering a return of -88% compared to S&P/ASX 300's 3% drop.

Stocks Performance
ENL vs S&P/ASX 300

Loading...
ENL
S&P/ASX 300
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ENL vs S&P/ASX 300

Performance Gap Between ENL and AXKO
LOCKED
Unlock

Performance By Year
ENL vs S&P/ASX 300

Loading...
ENL
S&P/ASX 300
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Enlitic Inc vs Peers

S&P/ASX 300
ENL
VEEV
PME
2413
SECT B
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Enlitic Inc
Glance View

Market Cap
30.8m AUD
Industry
Health Care

Enlitic, Inc. provides diagnostic healthcare services. The company is headquartered in Fort Collins, Colorado. The company went IPO on 2023-12-19. The company is focused on developing tools that solve longstanding challenges in radiology rather than developing point solutions that exacerbate the issues radiology faces. Its products include ENDEX, ENCOG, ENCODE, and ENSIGHT. ENDEX transforms new and historical medical image data descriptions to a consistent, clinically relevant standard nomenclature that impacts workflows and capacity within and beyond radiology. ENCOG deidentifies and anonymizes imaging data to remove PHI from pixel data, metadata, and private tags while retaining clinically relevant information.

ENL Intrinsic Value
LOCKED
Unlock
Back to Top